Please login to the form below

Not currently logged in
Email:
Password:

eTheRNA

This page shows the latest eTheRNA news and features for those working in and with pharma, biotech and healthcare.

AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance

AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance

Nevertheless, biotech company eTheRNA has launched the development of a cross-strain protective coronavirus vaccine for high-risk populations. ... Viral variation means traditional medicinal and preventive vaccine approaches may fall short when

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • New hires at Crescendo, Healx and Galecto New hires at Crescendo, Healx and Galecto

    He joins Galecto from eTheRNA immunotherapies, a Belgian mRNA immunotherapy company. ... Prior to eTheRNA, Lindmark served as global VP of clinical development for the respiratory and inflammation franchises at AstraZeneca.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...